Profile data is unavailable for this security.
About the company
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. Its pharmaceutical business features Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage three or four chronic kidney disease (CKD) and vitamin D insufficiency, and Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. Its NGENLA (somatrogon-ghla), is a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older.
- Revenue in USD (TTM)711.41m
- Net income in USD-133.73m
- Incorporated1991
- Employees3.93k
- LocationOPKO Health Inc4400 Biscayne Blvd.MIAMI 33137United StatesUSA
- Phone+1 (305) 575-4181
- Websitehttps://www.opko.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| InnovAge Holding Corp | 786.51m | -15.96m | 636.83m | 2.35k | -- | 2.44 | 284.17 | 0.8097 | -0.1175 | -0.1175 | 5.79 | 1.93 | 1.47 | -- | 17.30 | 334,686.00 | -3.35 | -3.72 | -4.76 | -4.90 | 17.64 | 20.39 | -2.28 | -2.79 | -- | -2.30 | 0.2172 | -- | 11.01 | 10.41 | 47.54 | -- | -11.39 | -- |
| Agilon Health Inc | 5.35bn | -306.78m | 688.07m | 1.12k | -- | 1.20 | -- | 0.1285 | -0.7574 | -0.9521 | 13.13 | 1.40 | 2.45 | -- | 3.95 | 4,792,792.00 | -14.04 | -- | -36.97 | -- | 2.00 | -- | -5.73 | -- | -- | -- | 0.0572 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
| QDM International Inc | 3.93m | 1.30m | 790.14m | 5.00 | 606.26 | 180.97 | 587.92 | 201.15 | 0.0045 | 0.0045 | 0.0135 | 0.015 | 0.5994 | -- | 21.84 | 785,618.00 | 19.86 | -- | 34.36 | -- | 61.80 | -- | 33.13 | -- | -- | 436.13 | 0.2444 | -- | 461.81 | -- | 3,411.87 | -- | -- | -- |
| AMN Healthcare Services, Inc. | 3.07bn | 53.04m | 944.23m | 3.59k | 17.87 | 1.06 | 4.13 | 0.3078 | 1.39 | 1.39 | 80.25 | 23.43 | 1.15 | -- | 4.86 | 855,604.20 | 1.99 | 9.32 | 2.59 | 12.41 | 31.34 | 32.96 | 1.73 | 6.62 | -- | 2.00 | 0.5594 | 0.00 | -27.73 | 12.15 | -52.56 | 8.25 | 23.70 | -- |
| Brookdale Senior Living, Inc. | 3.10bn | -209.17m | 1.04bn | 25.20k | -- | 3.55 | 6.87 | 0.3356 | -0.924 | -0.924 | 13.68 | 1.47 | 0.5267 | -- | 61.66 | 122,977.10 | -3.56 | -2.20 | -4.07 | -2.48 | 25.68 | 21.71 | -6.75 | -4.40 | -- | 0.2534 | 0.9361 | -- | 6.74 | -7.82 | 20.73 | -- | -12.60 | -- |
| Pennant Group Inc | 652.30m | 21.15m | 1.06bn | 5.79k | 44.75 | 5.51 | 37.84 | 1.62 | 0.6879 | 0.6879 | 21.25 | 5.59 | 1.12 | -- | 9.10 | 112,640.60 | 3.83 | 1.81 | 4.54 | 2.14 | 20.55 | 21.62 | 3.42 | 1.92 | -- | 4.24 | 0.3676 | 0.00 | 15.14 | 13.76 | 101.40 | -3.13 | 14.07 | -- |
| OPKO Health Inc | 711.41m | -133.73m | 1.08bn | 3.93k | -- | 0.7684 | -- | 1.52 | -0.1831 | -0.1831 | 0.9983 | 2.06 | 0.3299 | 8.30 | 6.35 | 181,019.80 | -6.20 | -7.14 | -6.86 | -8.14 | 25.10 | 34.42 | -18.80 | -13.83 | 2.69 | -5.36 | 0.2418 | -- | -14.01 | -2.70 | 42.49 | -- | -10.19 | -- |
| Aveanna Healthcare Holdings Inc | 1.98bn | -65.85m | 1.11bn | 3.50k | -- | -- | -- | 0.5621 | -0.3438 | -0.3438 | 10.26 | -0.8021 | 1.20 | -- | 7.56 | 566,707.10 | -3.99 | -- | -5.21 | -- | 30.87 | 31.12 | -3.32 | -12.71 | -- | 0.7906 | 1.12 | -- | 6.02 | 8.62 | 79.68 | -- | -20.76 | -- |
| Pediatrix Medical Group Inc | 2.01bn | -253.84m | 1.24bn | 2.90k | -- | 1.70 | -- | 0.62 | -3.07 | -3.07 | 24.07 | 8.53 | 0.9116 | -- | 7.11 | 692,068.30 | -11.53 | 0.8579 | -13.80 | 0.9945 | -- | -- | -12.65 | 1.52 | -- | 4.84 | 0.4611 | 0.00 | 1.15 | 2.97 | -196.55 | -- | 14.25 | -- |
| Progyny Inc | 1.14bn | 57.27m | 1.26bn | 563.00 | 24.10 | 2.84 | 20.96 | 1.11 | 0.5801 | 0.5801 | 11.57 | 4.92 | 1.64 | -- | 4.14 | 2,022,611.00 | 8.26 | 11.50 | 11.63 | 16.02 | 21.68 | 21.48 | 5.03 | 6.64 | -- | -- | 0.00 | 0.00 | 38.34 | 59.52 | 104.35 | -- | 44.47 | -- |
| US Physical Therapy Inc | 645.70m | 14.10m | 1.42bn | 3.90k | 100.58 | 2.94 | 29.02 | 2.20 | 0.9352 | 0.9352 | 42.93 | 32.02 | 0.6332 | -- | 8.70 | 165,606.30 | 3.12 | 7.13 | 4.31 | 10.64 | 19.41 | 21.96 | 4.93 | 9.71 | -- | 45.42 | 0.1753 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
| Teladoc Health Inc | 2.59bn | -981.73m | 1.55bn | 5.60k | -- | 1.03 | -- | 0.5984 | -5.78 | -5.78 | 15.33 | 8.77 | 0.6592 | 20.73 | 12.39 | 462,430.30 | -24.99 | -33.54 | -30.10 | -34.63 | 70.82 | 68.59 | -37.91 | -171.39 | 1.69 | -- | 0.5055 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
Data as of Nov 21 2024. Currency figures normalised to OPKO Health Inc's reporting currency: US Dollar USD
21.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rubric Capital Management LPas of 30 Sep 2024 | 48.71m | 6.98% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 28.62m | 4.10% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 25.75m | 3.69% |
| KSM Mutual Funds Ltd.as of 31 Jul 2024 | 9.41m | 1.35% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 8.72m | 1.25% |
| Geode Capital Management LLCas of 30 Sep 2024 | 8.37m | 1.20% |
| Migdal Mutual Funds Ltd.as of 31 Jul 2024 | 6.23m | 0.89% |
| Invesco Capital Management LLCas of 30 Sep 2024 | 6.02m | 0.86% |
| Charles Schwab Investment Management, Inc.as of 30 Sep 2024 | 4.21m | 0.60% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2024 | 3.48m | 0.50% |
More ▼
Data from 31 Jul 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
